Laser Capture Microdissection Market - Databook 2025 to 2034

The global laser capture microdissection market size surpassed USD 205 million in 2024 and is predicted to reach around USD 467.79 million by 2034, registering a CAGR of 8.6% from 2025 to 2034.

Highlights of the Laser Capture Microdissection Market

• North America dominated the laser capture microdissection market in 2024.
• Asia-Pacific region is expected to show the fastest growth in the forecasted period of 2025-2034.
• By type, the consumables segment dominated the market in 2024.
• By type, the software segment is predicted to have the fastest growth in the forecasted period.
• By application, the research & development segment will have contributed to the major market share in 2024.
• By application, the diagnostics segment is predicted to have a rapid growth in the forecasted period.
• By end-use, the academic & research institutes segment dominated the market in 2024.
• By end-use, the pharmaceutical & biotech companies segment will gain a significant share of the market over the studied period of 2025 to 2034.

Industry Valuation and Growth Rate Projection

Laser capture microdissection is a technique wherein the specific cells from mixed populations are separated to be observed under microscopic visualization. This technique aids in getting more accurate and efficient results for analyzing the gene expression due to differences between the cell types that are present within normal tissue and have significant effects on the gene expression. It is used for cancer research, toxicology, neuroscience and other applications like plant biology, forensics, and drug discovery.

The laser capture microdissection market is booming rapidly with government and private institutions' heavy expenditure on healthcare and R&D in biopharmaceutical markets. With the advancements in technologies and heavy investment in research and development the market is striving forward with more advanced biotechnology, with more cost effective, accurate and efficient measures.

Laser Capture Microdissection Market: Stats and Figures

• The COVID-19 pandemic led to approximately one million missed cancer diagnoses worldwide, with a 23% decrease in new cancer cases reported in 2020 due to healthcare disruptions.
• The World Health Organization (WHO) forecasts a 77% rise in global cancer cases by 2050, escalating from 20 million new cases in 2022 to over 35 million.
• In gene expression analysis, the virus-mediated single-cell knockout method resulted in a reduction of 92% in target gene RNA compared to the wild-type neurons with a 10-fold increase in mRNA levels of the fluorescent protein.
• 94% efficiency is achieved across all tissues in second-generation rats with progressive isotope labeling, which makes it highly efficient, accurate, and reliable for proteomic analysis in complex organs such as the brain.

How AI has Benefitted the Laser Capture Microdissection Market

Artificial intelligence (AI) has made a significant mark in the laser capture microdissection market.

• The integration of AI-driven automated laser guidance and image recognition enhances efficiency, quality, and accuracy.
• Higher sampling is possible with the adoption of next-gen polymer-coated slides with infrared laser systems.
• AI and machine learning help integrate data insights with tech for better and quicker results.
• AI has helped businesses streamline their business models for more efficiency with fewer human errors and provides strong support to handle repetitive tasks.

Industry Leader Announcements

• Murali Venkatesan, Vice President of Science, Technology and Innovation, Danaher Corporation, said-

"Danaher is committed to ethically using AI to develop and deliver better diagnostics to help doctors treat their patients with the right medicine in the right dose at the right time."

• Trisha Rice, vice president and general manager of life sciences for the electron microscopy business of Thermo Fisher Scientific, said-

“Broadening our understanding of basic cellular biology has the potential to unlock new layers of scientific research and therapeutic development, empowering researchers across the globe to uncover new insights in their labs,”

Geographical Insights

North America

North America dominated the global laser capture microdissection market in 2024. The rapid advancements in technology and investment in research and development on biotechnology by the government and private institutions boost the market's growth. Furthermore, the presence of global key players with advanced healthcare technology focusing on cancer research, personalized medicine, and genomics also contribute as the market drivers for the region.

APAC

Asia Pacific is the fastest-growing region in the forecasted period of 2025-2034 in the laser capture microdissection market. The region contains many former and emerging businesses that are growing rapidly and contributing to the healthcare field with their focus on biopharmaceutical products and investments in research and development and biotech.

Europe

Europe region is expected to grow rapidly in the forecasted period with their governments spending heavily on healthcare and research and development in the field of biotechnology with a major focus on advancing cancer research, personalized medicine, and genomics.

Recent Developments

• In January 2025, Danaher announced an investment partnership with Innovaccer Inc. A leading healthcare AI company. This partnership aims to strengthen its network of healthcare systems and facilitate value-based care by the adoption of precision diagnostics by clinicians and population health teams.
• In April 2024, Bio-Techne entered into a strategic distribution agreement with Thermo Fisher Scientific to provide cutting-edge solutions to its customers. These two industry leaders in the fields of research, biotechnology, and diagnostics under this agreement shall distribute Bio-Techne's extensive portfolio of products to the European market through Fisher Scientific’s channel.
• In Dec 2023, Danaher came into an agreement with Abcam to acquire Abcam shares at US$24.00 per share, wherein Abcam will continue to work independently. This acquisition supports Danaher's strategy to use its technology to better understand complex diseases and speed up drug discovery.

Competitive Landscape

The laser capture microdissection market is highly competitive with leading players all around the world, like Thermo Fisher Scientific, Danaher, Carl Zeiss Meditec AG, Molecular Machines & Industries GmbH and Standard BioTools Inc and many more striving to gain the largest market share globally by heavily investing on research and development in the healthcare field.

The market is dominated by several companies, but the companies that are renowned for their contribution to the market are listed below:

• Company Name: Thermo Fisher Scientific
• Year of Incorporation: 2006
• Headquarters: Waltham, Massachusetts

Thermo Fisher Scientific was established by a merger between Thermo Electron and Fisher Scientific. It provides many kinds of products and services throughout 600+ locations across America, APAC, and EMEA regions. It has provided a significant contribution to the immunotoxins market, with a revenue of USD 42.88 billion in the year 2024.

• Company Name: Danaher
• Year of Incorporation: 1984
• Headquarters: Washington, D.C, US

Danaher Corp. is a conglomerate company that is widely known for its cutting-edge innovations in biotech, diagnostics, and life science businesses. Danaher recorded a revenue of US$ 23,875 million in 2024.

• Company Name: Carl Zeiss Meditec AG
• Year of Incorporation: 2002
• Headquarters: Jena, Germany

Carl Zeiss Meditec AG is a leading medical technology company and is a subsidiary of Carl Zeiss AG, specializing in microsurgery and ophthalmology. Carl Zeiss Meditec AG recorded a revenue of US$ 2,880 million in 2024.